Vivos Therapeutics wins new US patent covering Vivos CARE oral device technology

• Vivos Therapeutics received US Patent No. 12,697,190 covering a vibrational oral appliance with mandibular advancements for its Vivos CARE devices.
• The new patent is a continuation of US Patent No. 12,048,608, issued July 30, 2024, expanding intellectual property coverage around the platform.
• Vivos CARE has FDA 510(k) clearances to treat severe OSA in adults, moderate-to-severe OSA in children ages 6-17.
• The company cited studies showing about 80% of patients had significant AHI reductions or symptom resolution using Vivos CARE.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608050830PRIMZONEFULLFEED9804166) on August 05, 2026, and is solely responsible for the information contained therein.